trending Market Intelligence /marketintelligence/en/news-insights/trending/c991gqkz9feE8T4sSKH4Pg2 content
Log in to other products

Login to Market Intelligence Platform

 /


Looking for more?

Contact Us
In This List

Antibe Therapeutics completes private placement, raises C$2.7M

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry

Segment

IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help


Antibe Therapeutics completes private placement, raises C$2.7M

Antibe Therapeutics Inc. completed the second and final closing of its private placement, raising another C$297,750 in gross proceeds to bolster the C$2.4 million raised in the first tranche of the offering.

The net proceeds of approximately C$2.7 million will be used for clinical development and general purposes.

The issued securities are subject to a four-month statutory hold period and a TSX Venture Exchange hold period, each expiring April 22, 2017.